Activation of mutant EGFR in murine bronchial epithelial cells induced the upregulation of PD-1, PD-L1, and CTLA-4, while EGFR inhibitors inhibited the expression of PD-L1 in NSCLC cell lines. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.